Characterization of the T cell receptor repertoire and melanoma tumor microenvironment upon combined treatment with ipilimumab and hTERT vaccinationEspen B. Ellingsen, Gustav Gaudernack, Tormod Kyrre Guren et al.|Journal of Translational Medicine|2022Cited by 21
Personalized <scp>HLA</scp> typing leads to the discovery of novel <scp>HLA</scp> alleles and tumor‐specific <scp>HLA</scp> variantsIrantzu Anzar, Trevor Clancy, Angelina Sverchkova et al.|HLA|2022Cited by 16
382 The synthetic long peptide cancer vaccine UV1 in combination with ipilimumab induces a CD4+ Th1 anti-hTERT immune response and an inflammatory tumor microenvironment in patients with melanomaEspen B. Ellingsen, Gustav Gaudernack, Eivind Hovig et al.|Regular and Young Investigator Award Abstracts|2021Cited by 0